[1]
|
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis
Cell Death Discovery,
2023
DOI:10.1038/s41420-023-01551-6
|
|
|
[2]
|
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
Cancers,
2021
DOI:10.3390/cancers13215448
|
|
|
[3]
|
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
Cancers,
2021
DOI:10.3390/cancers13215448
|
|
|
[4]
|
Vitamin K Dependent Proteins in Kidney Disease
International Journal of Molecular Sciences,
2019
DOI:10.3390/ijms20071571
|
|
|
[5]
|
Vitamin K Dependent Proteins in Kidney Disease
International Journal of Molecular Sciences,
2019
DOI:10.3390/ijms20071571
|
|
|
[6]
|
Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma
Journal of Cancer Therapy,
2017
DOI:10.4236/jct.2017.82010
|
|
|
[7]
|
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Cell Death and Disease,
2017
DOI:10.1038/cddis.2017.554
|
|
|
[8]
|
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Cell Death & Disease,
2017
DOI:10.1038/cddis.2017.554
|
|
|
[9]
|
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
Journal of Hepatology,
2015
DOI:10.1016/j.jhep.2015.04.013
|
|
|